Stock Code
688016.SH
Stock Code
688016.SH
Senior Management
Mr. Lantao Guo, born in 1965, is an American national and holds a Ph.D. in Material Science from State University of New York. Mr. Guo served as R&D scientist of Procter & Gamble from 1997 to 2000; materials project engineer and principal engineer of Becton Dickinson from 2000 to 2008; principal engineer of Stryker from 2008 to 2013; R&D director of Edwards Lifesciences from 2013 to 2017; R&D director and other roles of Reshape Lifesciences from 2017 to 2019; and deputy general manager of Endovastec? and general manager of VasoLutions? from August 2020 to January 2023. Since February 2023, he has been advanced vice president of the North American R&D Center of Endovastec US?.
Mr. Lantao Guo, born in 1965, is an American national and holds a Ph.D. in Material Science from State University of New York. Mr. Guo served as R&D scientist of Procter & Gamble from 1997 to 2000; materials project engineer and principal engineer of Becton Dickinson from 2000 to 2008; principal engineer of Stryker from 2008 to 2013; R&D director of Edwards Lifesciences from 2013 to 2017; R&D director and other roles of Reshape Lifesciences from 2017 to 2019; and deputy general manager of Endovastec? and general manager of VasoLutions? from August 2020 to January 2023. Since February 2023, he has been advanced vice president of the North American R&D Center of Endovastec US?.
About us
News
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
?Copyright 1998-2020, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2020-0065
Website record/ license No.：滬ICP備14048493號-1 
HGWA Bei No.31011502014536
The registered trademarks of “微創", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
